Disability versus Difference over Development in the Autisms
This project aims to develop the AUTISMS-3D model to differentiate autism subtypes based on disability versus difference, enhancing understanding and treatment through data-driven stratification and neurobiological analysis.
Projectdetails
Introduction
Autism is an early developing condition diagnosed on the basis of difficulties in the domains of social-communication and restricted repetitive behaviors. However, the single label of ‘autism’ masks a large degree of heterogeneity at multiple scales, from genome to phenome, and may not signal differential needs and services required for some types of profoundly affected individuals.
Research Goals
In order to better understand autism and develop more impactful ways to facilitate positive outcomes at an individualized level, we need better models that help to explain how autism may be differentiated in meaningful ways. This differentiation can help explain variability in:
- Developmental paths
- Responses to treatment
- Differential underlying neurobiological mechanisms
AUTISMS-3D Model
This research program develops and tests the AUTISMS-3D model – disability versus difference over development - as a first-level major distinction for explaining heterogeneity within the autism population.
Key Postulate
AUTISMS-3D postulates that the major first-level split within the autism population is between subtypes described by:
- Profound disability
- Difference in developmental outcomes
Stratification Models
Stratification models using standardized clinical measures of intellectual functioning, language, and adaptive behavior will be used to predict ‘disability’ versus ‘difference’ subtypes. These stratification models are based on highly reproducible data-driven clustering analyses from very large phenotypic datasets.
Developmental Analysis
We will then test how the subtypes may develop differently with analyses of big clinical longitudinal datasets and also within the context of early intervention.
Neurobiological Testing
Finally, we will test the subtypes for neurobiological differences via:
- Neuroimaging (MRI, fMRI, DTI)
- Electrophysiological (EEG)
- Gaze phenotypes (e.g., eye tracking) under static and naturalistic viewing conditions.
Conclusion
The research will help refine our understanding and concepts of autism and will be an important next step on the path to precision medicine for the autisms.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.750 |
Totale projectbegroting | € 1.999.750 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIApenvoerder
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disordersThis project aims to investigate the role of extracellular proteins in brain development and autism spectrum disorders using advanced techniques to identify and analyze their effects. | ERC Consolid... | € 1.997.729 | 2022 | Details |
Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorderSUBTREAT aims to enhance treatment for major depressive disorder by identifying subtypes through advanced data science, exploring their causes, and developing predictive algorithms for tailored therapies. | ERC Starting... | € 1.500.000 | 2022 | Details |
Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.This project aims to identify Alzheimer's disease subtypes through CSF proteomics to develop tailored treatments and theragnostic tools linked to cognitive decline and genetic factors. | ERC Consolid... | € 2.999.934 | 2025 | Details |
COgnitive Dynamics in Early ChildhoodThis project aims to investigate the short-term variability in cognitive performance among children and its impact on long-term outcomes, using advanced measurement techniques over three years. | ERC Starting... | € 1.500.000 | 2023 | Details |
Enhancing Synchrony in Autism: Introducing the MirrorPods-Intervention PlatformAUTISMsync develops MirrorPods, an innovative intervention platform using technology and human interaction to enhance temporal synchrony in autistic child-parent dyads, aiming to improve behavioral therapies. | ERC Proof of... | € 150.000 | 2025 | Details |
Toward an understanding of the brain interstitial system and the extracellular proteome in health and autism spectrum disorders
This project aims to investigate the role of extracellular proteins in brain development and autism spectrum disorders using advanced techniques to identify and analyze their effects.
Subtype as a key to reduce heterogeneity of treatment effects in major depressive disorder
SUBTREAT aims to enhance treatment for major depressive disorder by identifying subtypes through advanced data science, exploring their causes, and developing predictive algorithms for tailored therapies.
Deciphering Alzheimer’s disease molecular subtypes to advance treatment development.
This project aims to identify Alzheimer's disease subtypes through CSF proteomics to develop tailored treatments and theragnostic tools linked to cognitive decline and genetic factors.
COgnitive Dynamics in Early Childhood
This project aims to investigate the short-term variability in cognitive performance among children and its impact on long-term outcomes, using advanced measurement techniques over three years.
Enhancing Synchrony in Autism: Introducing the MirrorPods-Intervention Platform
AUTISMsync develops MirrorPods, an innovative intervention platform using technology and human interaction to enhance temporal synchrony in autistic child-parent dyads, aiming to improve behavioral therapies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEaseThe MIRACLE project aims to develop advanced multiomics-based risk prediction models for atherosclerotic cardiovascular disease by integrating genetic data and biomarkers for improved early diagnosis and treatment. | EIC Pathfinder | € 4.000.000 | 2023 | Details |
S4E-platform: Simulaties en Signaaldetectie voor EpilepsieHet project ontwikkelt een AI-platform (S4E) voor het voorspellen van epilepsiesubtypes via hersensimulaties en fNIRS, om diagnostiek en behandeling te verbeteren. | Mkb-innovati... | € 331.450 | 2023 | Details |
MultiomIcs based Risk stratification of Atherosclerotic CardiovascuLar disEase
The MIRACLE project aims to develop advanced multiomics-based risk prediction models for atherosclerotic cardiovascular disease by integrating genetic data and biomarkers for improved early diagnosis and treatment.
S4E-platform: Simulaties en Signaaldetectie voor Epilepsie
Het project ontwikkelt een AI-platform (S4E) voor het voorspellen van epilepsiesubtypes via hersensimulaties en fNIRS, om diagnostiek en behandeling te verbeteren.